Avid Bioservices (CDMO) Misses Q1 EPS by 1c, beats revenue, offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures slide as rising oil, yields dampen mood
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
Tweet
Share
E-mailGet Alerts CDMO Hot Sheet
Join SI Premium – FREE
Avid Bioservices (NASDAQ: CDMO) reported Q1 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $37.7 million versus the consensus estimate of $37.06 million.
GUIDANCE:
Avid Bioservices sees FY 2024 revenue of $145-165 million.
For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Helen of Troy (HELE) Tops Q2 EPS by 28c, Misses on Revenue; Offers FY27 Guidance
- Richardson Electronics (RELL) Tops Q1 EPS by 17c
- PepsiCo (PEP) Tops Q3 EPS by 4c, cuts EPS forecast
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
